Comparison
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227 vs 2 Oxoadipic Aciduria C4011938
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Androgens Excess and 2 Oxoadipic Aciduria for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
A condition where an XX individual has excess male hormones causing atypical genital development. It affects both newborns and older individuals. Treatment may involve hormone management and surgical options.
2 Oxoadipic Aciduria C4011938
A metabolic condition affecting the breakdown of lysine and tryptophan. Acidic byproducts accumulate and may cause health issues. Managed with specialized diet and monitoring.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
0-null
2 Oxoadipic Aciduria C4011938
0-18
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
severe
2 Oxoadipic Aciduria C4011938
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
Chronic
2 Oxoadipic Aciduria C4011938
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
No
2 Oxoadipic Aciduria C4011938
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
reproductive
2 Oxoadipic Aciduria C4011938
metabolic
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
endocrine
2 Oxoadipic Aciduria C4011938
metabolic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-androgens-excess-C5680227 and 2-oxoadipic-aciduria-C4011938 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227 | 2 Oxoadipic Aciduria C4011938 | Discriminating power |
|---|---|---|---|
| Genital development | An XX person may have atypical or virilized genitalia from androgen excess. | Genital development is not the defining feature. | High |
| Organic-acid accumulation | Not characterized here as a lysine or tryptophan breakdown disorder. | Acidic byproducts of lysine and tryptophan metabolism may accumulate. | High |
| Neurologic features | Not established as a core feature from the supplied data. | Clinical effects vary and are not definitive for every person. | Moderate |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227 when
Atypical genitalia in an XX newborn or older person
The supplied description centers on androgen-related genital development.
High
Endocrine evaluation shows androgen excess
Hormone findings fit the reproductive-endocrine category better than an organic aciduria.
Moderate
Care focuses on sex development and hormones
Management may involve hormone care and consideration of surgery.
Moderate
Choose 2 Oxoadipic Aciduria C4011938 when
Urine organic acids suggest 2-oxoadipic acid accumulation
This biochemical pattern points toward the metabolic condition.
High
Lysine or tryptophan metabolism is being investigated
The source specifically links the condition to those pathways.
Moderate
Management centers on diet and monitoring
The supplied description emphasizes specialized diet and follow-up.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227 | 2 Oxoadipic Aciduria C4011938 | Interpretation |
|---|---|---|---|
| Karyotype | 46,XX supports the chromosomal context. | No characteristic karyotype is established. | Karyotype alone does not prove androgen excess or aciduria. |
| Androgen assessment | Excess androgens may be documented. | Androgen excess is not the defining abnormality. | Exact cutoffs are not supplied and need clinician interpretation. |
| Urine organic acids | No characteristic organic-acid pattern is established. | 2-oxoadipic acid or related metabolites may be increased. | An abnormal result is not automatically a complete diagnosis. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
- Outcome
- Chronic course with variable outcome; exact prognosis is not established.
- Factors
- Cause, anatomy, hormone management, and psychosocial support.
2 Oxoadipic Aciduria C4011938
- Outcome
- Chronic and often variable; some effects may be mild or uncertain.
- Factors
- Metabolite burden, diet management, monitoring, and any neurologic findings.
Time frame: Both may require long-term care; metabolic onset is described from birth to 18 years.
No mortality comparison or definitive outcome is established.
Complications comparison
| Complication | Presentation |
|---|---|
| Psychosocial distress | May relate to genital difference, identity, and treatment decisions. May relate to uncertainty and long-term metabolic monitoring. Impact varies; no comparative frequency is established. |
| Reproductive effects | Fertility and sexual function may be affected, but outcomes vary. Reproductive involvement is not established by the supplied data. Specialist counseling is appropriate. |
| Metabolic instability | Not established as a core complication. Accumulated metabolites may cause health issues in some people. Severity and triggers are not defined here. |
Patient education highlights
- HighDifferent conditions
One concerns sex development from androgen excess; the other concerns metabolic byproducts.
- HighSpecialist interpretation
Abnormal hormones or organic acids need confirmation and clinical context.
- MediumTreatment changes
Do not change hormones, diet, or surgery plans without the treating clinician.